StockData
Cue Biopharma, Inc. logo

Cue Biopharma, Inc. (CUE) income statement

CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/30
$4.15−0.35 (-7.78%)

Close on Nov 20, 2026Market cap $30.15MP/E –Yield –

See a number that looks wrong?